Exploratory analysis of exosomes derived from ascites and serum of patients with peritonitis carcinomatosa

Exploratory analysis of exosomes derived from ascites and serum of patients with peritonitis carcinomatosa - Exploratory analysis of exosomes derived from ascites and serum of patients with peritonitis carcinomatosa

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020296

Enrollment

Registered

2015-12-24

Start date

2015-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal cancer

Interventions

abdominocentesis (a period of time:-March 31 2018, an amout:20ml, times:1-several time)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients who underwent abdominocentesis and/or cell-free and concentrated ascites reinfusion therapy (CART) 2. Written informed consent for participation in this study is obtained 3. > 20 years-old

Exclusion criteria

Exclusion criteria: 1. Patients with the bleeding tendency 2. Patients with the infection or side vice-blood circulation road in the puncture part 3. Patients with the adhesion in a wide range of abdominal cavity or the high intestinal tract expansion 4. Patients who cannot keep rest 5. Patients who has extremely decreased whole body state 6. Patients who cannot carry out this examination safely

Design outcomes

Primary

Measure	Time frame
Relationship between exosome-derived melecules and chemoresistance/prognosis	—

Countries

Japan

Contacts

Public ContactTakahiko sakaue

Department of Medicine, Kurume University School of Medicine Division of Gastroenterology

sakaue_takahiko@med.kurume-u.ac.jp0942-31-7561

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026